Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Hypersensitivity

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,455 public trials 324 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma

NCT01257230

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: 205.444.01004 Boehringer Ingelheim Investigational Site Plymouth, Minnesota, United States

205.444.01005 Boehringer Ingelheim Investigational Site Columbia, Missouri, United States

205.444.01001 Boehringer Ingelheim Investigational Site Cincinnati, Ohio, United States

205.444.01014 Boehringer Ingelheim Investigational Site Oklahoma City, Oklahoma, United States

View all 66 locations

View Trial Details

Completed

Single Dose Bronchodilatory Study in Asthma

NCT01805687

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Northeast Medical Research Associates North Dartmouth, Massachusetts, United States

View Trial Details

Completed

Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis

NCT00152412

Conditions: Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
Locations: Not specified

View Trial Details

Completed

Imaging Lung Function Using Oxygen Enhanced MRI

NCT01731015

Conditions: Asthma, Bronchial Diseases, COPD, +20 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)

NCT02220673

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

BALLOON (Corticosteroid/laBA inhaLers in adoLescents' Asthma: Assessment Of Patients satisfactiON) Study

NCT01708486

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Hippokrateion University Hospital Thessaloniki, Greece

View Trial Details

Completed

Drug Interaction Study of Azithromycin and Theophylline

NCT02023554

Conditions: Asthma, Bronchial Diseases, Chronic Disease, +12 more
Locations: Zhujiang Hospital,Southern Medical Universtiy Guangzhou, Guangdong, China

View Trial Details

Completed

Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)

NCT00772538

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: 205.416.01007 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

205.416.01012 Boehringer Ingelheim Investigational Site Los Angeles, California, United States

205.416.01018 Boehringer Ingelheim Investigational Site Los Angeles, California, United States

205.416.01016 Boehringer Ingelheim Investigational Site Riverside, California, United States

View all 73 locations

View Trial Details

Completed

Aerosolized Beta-Agonist Isomers in Asthma

NCT02170532

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

NCT01696071

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: 205.441.43004 Boehringer Ingelheim Investigational Site Grieskirchen, Austria

205.441.43003 Boehringer Ingelheim Investigational Site Linz, Austria

205.441.43001 Boehringer Ingelheim Investigational Site Thalheim bei Wels, Austria

205.441.43002 Boehringer Ingelheim Investigational Site Wels, Austria

View all 22 locations

View Trial Details